Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk J A R Moes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Transplantation|October 4, 2022
Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trialBastian N Ruijter, Maarten E Tushuizen, Dirk J A R Moes, et al.
The Pediatric Infectious Disease Journal|November 12, 2020
Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort StudySophie J Jansen, Enrico Lopriore, Robbert G M Bredius, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 29, 2026
Towards Precision Piperacillin Dosing in the Critically IllDirk J A R Moes, Martine G Caris, Anne G Märtson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2022
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential MechanismSylvia D Klomp, Soufian Meziyerh, Maurits F J M Vissers, et al.
Transplant Immunology|June 18, 2019
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graftFloris C Loeff, Esther H M van Egmond, Dirk J A R Moes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2020
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokineticsSoufian Meziyerh, Tom C Zwart, Ronald W van Etten, et al.
Targeted Oncology|July 31, 2024
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous AtezolizumabMart P Kicken, Maarten J Deenen, Dirk J A R Moes, et al.
Journal for Immunotherapy of Cancer|June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanomaJessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Targeted Oncology|June 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab GovitecanDirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON studyMarlies E J Reinders, Koen E Groeneweg, Sanne H Hendriks, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Transplantation|October 4, 2022
Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trialBastian N Ruijter, Maarten E Tushuizen, Dirk J A R Moes, et al.
The Pediatric Infectious Disease Journal|November 12, 2020
Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort StudySophie J Jansen, Enrico Lopriore, Robbert G M Bredius, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 29, 2026
Towards Precision Piperacillin Dosing in the Critically IllDirk J A R Moes, Martine G Caris, Anne G Märtson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2022
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential MechanismSylvia D Klomp, Soufian Meziyerh, Maurits F J M Vissers, et al.
Transplant Immunology|June 18, 2019
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graftFloris C Loeff, Esther H M van Egmond, Dirk J A R Moes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2020
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokineticsSoufian Meziyerh, Tom C Zwart, Ronald W van Etten, et al.
Targeted Oncology|July 31, 2024
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous AtezolizumabMart P Kicken, Maarten J Deenen, Dirk J A R Moes, et al.
Journal for Immunotherapy of Cancer|June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanomaJessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Targeted Oncology|June 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab GovitecanDirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON studyMarlies E J Reinders, Koen E Groeneweg, Sanne H Hendriks, et al.
Pageof 2